Top Markets
Coin of the day
Hubei Biocause Pharmaceutical Co., Ltd. Hubei Biocause Pharmaceutical Co., Ltd.

Hubei Biocause Pharmaceutical Co., Ltd.

000627
Peringkat dalam Saham #9082
Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a... Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a multifaceted business. Its primary activities within China involve the provision of life and motor insurance policies. Additionally, the company is engaged in the pharmaceutical, chemical, and new energy fuel industries. Specifically, in the pharmaceutical field, it conducts contract research, development, and manufacturing of active pharmaceutical ingredients (APIs), intermediate compounds, and various drug forms such as tablets, granules, and capsules. Its chemical offerings include substances like dimethyl ether gas and a-chloropropionyl chloride. The firm also boasts an international presence, distributing its products to markets including the United States, the European Union, and other global locations.
Harga Saham
$0.2219522
Terakhir disinkronkan: 2025-09-11
Kapitalisasi Pasar
$1.10B
Perubahan (1 hari)
0.04%
Perubahan (1 tahun)
0.17%
Negara
CN
Perdagangan Hubei Biocause Pharmaceutical Co., Ltd. (000627)
Pendapatan untuk Hubei Biocause Pharmaceutical Co., Ltd. (000627)
Pendapatan pada Sep 2024 TTM: $11.64B
Menurut laporan keuangan terbaru dari Hubei Biocause Pharmaceutical Co., Ltd., pendapatan saat ini (TTM) adalah $11.64B. Pada tahun 2022, perusahaan menghasilkan pendapatan sebesar $7.19B penurunan dibandingkan dengan pendapatan pada tahun 2021 yang sebesar $7.80B. Pendapatan adalah jumlah total yang dihasilkan dari penjualan barang atau jasa. Tidak seperti laba, tidak ada pengeluaran yang dikurangkan.
Riwayat pendapatan Hubei Biocause Pharmaceutical Co., Ltd. dari 2000 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Mengubah
2026 (TTM) $11.64B 65.85%
2023 $7.02B -2.39%
2022 $7.19B -7.80%
2021 $7.80B 16.95%
2020 $6.67B -7.46%
2019 $7.21B 60.19%
2018 $4.50B -45.18%
2017 $8.21B 235.32%
2016 $2.45B 2,837.70%
2015 $83.33M -36.00%
2014 $130.20M -18.41%
2013 $159.58M 27.62%
2012 $125.04M -30.47%
2011 $179.84M -5.88%
2010 $191.07M 35.24%
2009 $141.29M 6.03%
2008 $133.26M 16.42%
2007 $114.46M 59.34%
2006 $71.83M 11.78%
2005 $64.26M 14.85%
2004 $55.95M 9.55%
2003 $51.07M 21.26%
2002 $42.12M -2.10%
2001 $43.02M 10.51%
2000 $38.93M 0.00%
Pendapatan untuk perusahaan serupa atau pesaing
Perusahaan Pendapatan Perbedaan Pendapatan Negara
$87.63B 652.59%
CN
$34.44B 195.80%
HK
- -
CA
- -
TW
- -
US